{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:35:13Z","timestamp":1648506913039},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.remn.2016.04.003","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T04:06:14Z","timestamp":1466309174000},"page":"298-305","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Basal 18F-FDG PET\/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment"],"prefix":"10.1016","volume":"35","author":[{"given":"G.A.","family":"Jim\u00e9nez Londo\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Garc\u00eda Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M.","family":"Poblete Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amo-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Calle Primo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Iba\u00f1ez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mart\u00ednez Sanch\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"L\u00f3pez-Fidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Solano Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00ednez Hell\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"D\u00edaz Morfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2016.04.003_bib0005","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma International prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.remn.2016.04.003_bib0010","first-page":"1258","article-title":"18F-FDG PET\/CT for monitoring the response of lymphoma to radioinmunotherapy","volume":"104","author":"Jacene","year":"2009","journal-title":"J Nucl Med"},{"issue":"Suppl. 6","key":"10.1016\/j.remn.2016.04.003_bib0015","doi-asserted-by":"crossref","first-page":"vi59","DOI":"10.1093\/annonc\/mdr388","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Dreyling","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0020","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"Relander","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cpet.2014.12.005","article-title":"Role of 2-deoxy-2-[18F]-fluoro-d-glucose-PET\/computed tomography in lymphoma","volume":"10","author":"Tirumani","year":"2015","journal-title":"PET Clin"},{"key":"10.1016\/j.remn.2016.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1259\/bjr.20140360","article-title":"Impact of (18) F-FDG PET\/CT on the staging and management of follicular lymphoma","volume":"87","author":"Metser","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.remn.2016.04.003_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3816\/CLM.2008.n.040","article-title":"Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?","volume":"8","author":"Janikova","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.remn.2016.04.003_bib0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","article-title":"Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma","volume":"37","author":"Barrington","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.04.003_bib0050","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.remn.2016.04.003_bib0055","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","article-title":"Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte","volume":"15","author":"Brice","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.remn.2009.04.004","article-title":"PET-CT with intravenous contrast in the evaluation of patients with lymphoma. Contribution to diagnostic indications","volume":"28","author":"Talavera Rubio","year":"2009","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.remn.2016.04.003_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000253026","article-title":"Utility of the Follicular Lymphoma International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients","volume":"122","author":"Formica","year":"2009","journal-title":"Acta Haemat"},{"key":"10.1016\/j.remn.2016.04.003_bib0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.leukres.2005.07.006","article-title":"Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment","volume":"30","author":"Arcaini","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.remn.2016.04.003_bib0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00259-012-2079-y","article-title":"FDG PET\/CT predictive role in follicular lymphoma","volume":"39","author":"Lopci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.04.003_bib0080","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","article-title":"Impact of (18) F-fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-Hodgkin lymphoma","volume":"71","author":"Wirth","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.remn.2016.04.003_bib0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00259-013-2441-8","article-title":"PET\/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study","volume":"41","author":"Tychyj-Pinel","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.04.003_bib0095","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0100","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18-fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non Hodgkin's lymphoma","volume":"23","author":"Sch\u00f6der","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10428190903440953","article-title":"SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in on-Hodgkin lymphoma","volume":"51","author":"Watanabe","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.remn.2016.04.003_bib0110","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00259-010-1539-5","article-title":"Diagnostic and prognostic impact of 18F-FDG PET\/CT in follicular lymphoma","volume":"37","author":"Le Dortz","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.04.003_bib0115","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00259-014-2822-7","article-title":"Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma","volume":"41","author":"Sasanelli","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2016.04.003_bib0120","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2011.35.0736","article-title":"Positron Emission Tomography-Computed Tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants","volume":"29","author":"Trotman","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0125","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-fluorodeoxy-glucose positron emisi\u00f3n tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"W\u00f6hrer","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0130","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","article-title":"The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: A retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi","volume":"24","author":"Luminari","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remn.2016.04.003_bib0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jclinpath-2013-201520","article-title":"Bone marrow trephine biopsy involvement by lymphoma: review of histopathological features in 511 specimens and correlation with diagnostic biopsy, aspirate and peripheral blood findings","volume":"67","author":"Sovani","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.remn.2016.04.003_bib0140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00256-014-1919-1","article-title":"Utility of quantitative FDG-PET\/CT for the detection of bone marrow involvement in follicular lymphom: a histopathological correlation study","volume":"43","author":"Adams","year":"2014","journal-title":"Skeletal Radiol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16300075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253654X16300075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T15:04:37Z","timestamp":1600787077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253654X16300075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2253654X16300075"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2016.04.003","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basal 18F-FDG PET\/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2016.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. y SEMNIM. All rights reserved.","name":"copyright","label":"Copyright"}]}}